Drugs / NEOSH101
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00471510 | May 2007 → Feb 2008 | androgenetic alopecia | Neosil, Inc. | Unknown | No outcome recorded |
| Phase 2 | NCT00418730 | Jan → Oct 2007 | androgenetic alopecia | Neosil, Inc. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NEOSH101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00471510 ↗ |
| Action | Inhibit | “tetrapeptide aldehyde proteasome inhibitor” NCT00418730 ↗ |
| Modality | Peptide | “tetrapeptide aldehyde proteasome inhibitor (NEOSH101)” NCT00418730 ↗ |
| Route | Topical | “topical NEOSH101” NCT00418730 ↗ |